NCT00883155View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Bupropion HCI 100 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

October 31, 1998

Study Completion Date

October 31, 1998

Conditions
Healthy
Interventions
DRUG

Bupropion HCl 100 mg Tablets (Invamed Inc.)

DRUG

Wellbutrin 100 mg Tablets (Glaxo Wellcome)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY